Let‐7a‐5p abrogates progression of papillary thyroid carcinoma cells by decreasing nuclear receptor subfamily 6 group a member 1‐mediated lipogenesis

Second generation androgen receptor antagonist, TQB3720 abrogates prostate cancer growth via AR/GPX4 axis activated ferroptosis

(2023) Zhongqing Zhang et al.   Frontiers in Pharmacology

SHCBP1 Promotes Papillary Thyroid Carcinoma Carcinogenesis and Progression Through Promoting Formation of Integrin and Collagen and Maintaining Cell Stemness

(2021) Houfa Geng et al.   Frontiers in Endocrinology

TP53-Activated lncRNA GHRLOS Regulates Cell Proliferation, Invasion, and Apoptosis of Non-Small Cell Lung Cancer by Modulating the miR-346/APC Axis

(2021) Ke Ren et al.   Frontiers in Oncology

Downregulation of miRNA-14669 Reverses Vincristine Resistance in Colorectal Cancer Cells through PI3K/AKT Signaling Pathway

(2021) Weihua Dong et al.   Recent Patents on Anti-Cancer Drug Discovery

miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis

(2020) Carmen Elena Condrat et al.   Cells

Molecular mechanism of targeted inhibition of HMGA2 via miRNAlet-7a in proliferation and metastasis of laryngeal squamous cell carcinoma

(2020) Li-Juan Ma et al.   BIOSCIENCE REPORTS

Global trends in thyroid cancer incidence and the impact of overdiagnosis

(2020) Mengmeng Li et al.   Lancet Diabetes & Endocrinology

let-7 miRNAs inhibit CHD7 expression and control auditory-sensory progenitor cell behavior in the developing inner ear

(2020) Lale Evsen et al.   DEVELOPMENT

Repression of Irs2 by let‐7 mi RNA s is essential for homeostasis of the telencephalic neuroepithelium

(2020) Virginia Fernández et al.   EMBO JOURNAL

hsa_circ_001653 upregulates NR6A1 expression and elicits gastric cancer progression by binding to microRNA‐377

(2020) Wuyuan Zhou et al.   EXPERIMENTAL PHYSIOLOGY

microRNA‐196a‐5p inhibits testicular germ cell tumor progression via NR6A1/E‐cadherin axis

(2020) Xiaowen Liu et al.   Cancer Medicine

Lipid metabolism and cancer

(2020) Xueli Bian et al.   JOURNAL OF EXPERIMENTAL MEDICINE

NR6A1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in HepG2 cells

(2019) Yinfang Wang et al.   Cell Communication and Signaling

Factors Associated with Acute Complications among Individuals with Type 1 Diabetes in China: The 3C Study

(2019) Wei Liu et al.   ENDOCRINE RESEARCH

Reprogramming of fatty acid metabolism in cancer

(2019) Nikos Koundouros et al.   BRITISH JOURNAL OF CANCER

MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1

(2018) Rui Li et al.   BIOMEDICINE & PHARMACOTHERAPY

MicroRNA-125a-5p Affects Adipocytes Proliferation, Differentiation and Fatty Acid Composition of Porcine Intramuscular Fat

(2018) Jingjing Du et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Emerging role of lipid metabolism alterations in Cancer stem cells

(2018) Mei Yi et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma

(2018) Dong-Mei Wu et al.   Cell Death & Disease

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation

(2018) Jacob O'Brien et al.   Frontiers in Endocrinology

MicroRNA-146b-5p as an oncomiR promotes papillary thyroid carcinoma development by targeting CCDC6

(2018) Meng Jia et al.   CANCER LETTERS

Let-7c-5p inhibits cell proliferation and induces cell apoptosis by targeting ERCC6 in breast cancer

(2017) Xiaonan Fu et al.   ONCOLOGY REPORTS

Cytoplasmic Lipid Accumulation Characteristic of the Cribriform Variant of Papillary Thyroid Carcinoma

(2017) Nami Takada et al.   PATHOBIOLOGY

Let-7a inhibits migration, invasion and tumor growth by targeting AKT2 in papillary thyroid carcinoma

(2017) Bin Zhou et al.   Oncotarget

Lipid desaturation - the next step in targeting lipogenesis in cancer?

(2016) Barrie Peck et al.   FEBS Journal

Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer

(2016) Enrico Garattini et al.   Oncotarget

Positive expression of NR6A1/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patients

(2016) Gong Cheng et al.   Oncotarget

Mean Platelet Volume Could be a Possible Biomarker for Papillary Thyroid Carcinomas

(2015) Suleyman Baldane et al.   Asian Pacific Journal of Cancer Prevention

Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells

(2015) TATSUYA IWASAKI et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1

(2015) KUI LIU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Predicting effective microRNA target sites in mammalian mRNAs

(2015) Vikram Agarwal et al.   eLife

Steroid Receptor Coactivator-3 Regulates Glucose Metabolism in Bladder Cancer Cells through Coactivation of Hypoxia Inducible Factor 1α

(2014) Wei Zhao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Let-7 represses Nr6a1 and a mid-gestation developmental program in adult fibroblasts

(2013) A. M. Gurtan et al.   GENES & DEVELOPMENT

MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer

(2013) QIFENG LUO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

MicroRNAs and other non-coding RNAs as targets for anticancer drug development

(2013) Hui Ling et al.   NATURE REVIEWS DRUG DISCOVERY

MicroRNA: Potential Targets for the Development of Novel Drugs?

(2013) Wei Wu   Drugs in research & development

Metastatic Dormancy and Progression in Thyroid Cancer: Targeting Cells in the Metastatic Frontier

(2011) Matthew D. Ringel   THYROID

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma

(2008) Yao-Tseng Chen et al.   MODERN PATHOLOGY